Toll-like receptors

Annual Review of Immunology

Volumn 21, Issue , 2003, Pages 335-376

  Takeda, Kiyoshi ^a,b   Kaisho, Tsuneyasu ^a,b,c   Akira, Shizuo ^a,b  

^a OSAKA UNIVERSITY   (Japan)

^b JAPAN SCIENCE AND TECHNOLOGY AGENCY   (Japan)

^c RIKEN   (Japan)

Author keywords

Drosophila; Innate immunity; Microbial components; MyD88; Signal transduction

Indexed keywords

ADAPTOR PROTEIN; BACTERIAL DNA; BCG VACCINE; BROPIRIMINE; DOUBLE STRANDED RNA; FLAGELLIN; IMIDAZOQUINOLINE DERIVATIVE; IMIQUIMOD; INTERFERON; LIGAND; LIPOPOLYSACCHARIDE; LOXORIBINE; PACLITAXEL; PEPTIDOGLYCAN; PROTEIN MYD 88; RESIQUIMOD; TOLL LIKE RECEPTOR; TOLL LIKE RECEPTOR 1; TOLL LIKE RECEPTOR 10; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 5; TOLL LIKE RECEPTOR 6; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR; UNCLASSIFIED DRUG; CELL SURFACE RECEPTOR; DIFFERENTIATION ANTIGEN; DROSOPHILA PROTEIN; IMMUNE DEFICIENCY PROTEIN, DROSOPHILA; IMMUNOGLOBULIN RECEPTOR; MEMBRANE PROTEIN; MYD88 PROTEIN, DROSOPHILA; MYD88 PROTEIN, HUMAN; MYD88 PROTEIN, MOUSE; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCING ADAPTOR PROTEIN; TEHAO PROTEIN, DROSOPHILA;

ANTIGEN SPECIFICITY; ANTIMICROBIAL ACTIVITY; BACTERIAL GENE; CELL TYPE; CELLULAR DISTRIBUTION; CELLULAR IMMUNITY; CPG ISLAND; CYTOKINE PRODUCTION; DROSOPHILA; DRUG POTENCY; GENE; GENE EXPRESSION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; GENETIC ANALYSIS; GENETIC CODE; GENOMICS; HOST RESISTANCE; HUMAN; IMMUNE DEFICIENCY; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNITY; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; IMMUNOREGULATION; IMMUNOSTIMULATION; INFECTION; INFLAMMATION; MAMMAL; MULTIGENE FAMILY; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; BIOLOGICAL MODEL; GENETICS; IMMUNOLOGY; INNATE IMMUNITY; METABOLISM; MOUSE; PHYLOGENY;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; ANTIGENS, DIFFERENTIATION; DROSOPHILA; DROSOPHILA PROTEINS; HUMANS; IMMUNITY, NATURAL; INFECTION; LIGANDS; MAMMALS; MEMBRANE GLYCOPROTEINS; MICE; MODELS, IMMUNOLOGICAL; MYELOID DIFFERENTIATION FACTOR 88; PHYLOGENY; RECEPTORS, CELL SURFACE; RECEPTORS, IMMUNOLOGIC; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTOR 5; TOLL-LIKE RECEPTORS; TRANSCRIPTION FACTORS;

EID: 0012929728     PISSN: 07320582     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.immunol.21.120601.141126     Document Type: Review

References (291)

1. Hoffmann JA, Kafatos FC, Janeway CA Jr, Ezekowitz RAB. 1999. Phylogenetic perspectives in innate immunity. Science 284:1313-18
2. Hashimoto C, Hudson KL, Anderson KV. 1988. The Toll gene of Drosophila, required for dorsal-ventral embryonic polaxity, appears to encode a transmembrane protein. Cell 52:269-79
3. Belvin MP, Anderson KV. 1996. A conserved signaling pathway: the Drosophila toll-dorsal pathway. Annu. Rev. Cell Dev. Biol. 12:393-416
4. Lemaitre B, Nicolas E, Michaut L, Reichhart J-M, Hoffmann JA. 1996. The dorsoventral regulatory gene cassette spatzle/Toll/cactus controls the potent antifungal response in Drosophila adults. Cell 86:973-83
5. Meng X, Khanuja BS, Ip YT. 1999. Toll receptor-mediated Drosophila immune response requires Dif, an NF-κB factor. Genes Dev. 13:792-97
6. Rutschmann S, Jung AC, Hetru C, Reichhart JM, Hoffmann JA, et al. 2000. The Rel protein DIF mediates the antifungal but not the antibacterial host defense in Drosophila. Immunity 12:569-80
7. Hedengren M, Asling B, Dushay MS, Ando I, Ekengren S, et al. 1999. Relish, a central factor in the control of humoral but not cellular immunity in Drosophila. Mol. Cell 4:827-37
8. Rutschmann S, Kilinc A, Ferrandon D. 2002. Cutting edge: The Toll pathway is required for resistance to Gram-positive bacterial infections in Drosophila. J. Immunol. 168:1542-46
9. Grosshans J, Bergmann A, Haffter P, Nusslein-Volhard C. 1994. Activation of the kinase Pelle by Tube in the dorsoventral signal transduction pathway of Drosophila embryo. Nature 372:563-66
10. Xiao T, Towb P, Wasserman SA, Sprang SR. 1999. Three-dimensional structure of a complex between the death domains of Pelle and Tube. Cell 99:545-55
11. Tauszig-Delamasure S, Bilak H, Capovilla M, Hoffmann JA, Imler J-L. 2001. Drosophila MyD88 is required for the response to fungal and Gram-positive bacterial infections. Nat. Immunol. 3:91-97
12. Horng T, Medhzitov R. 2001. Drosophila MyD88 is an adapter in the Toll signaling pathway. Proc. Natl. Acad. Sci. USA 98:12654-58
13. Levashina EA, Langley E, Green C, Gubb D, Ashburner M, et al. 1999. Constitutive activation of Toll-mediated antifungal defense in Serpin-deficient Drosophila. Science 285:1917-19
14. Michel T, Reichart J-M, Hoffmann JA, Royet J. 2001. Drosophila Toll activated by Gram-positive bacteria through a circulating peptidoglycan recognition protein. Nature 414:756-59
15. Werner T, Liu G, Kang D, Ekengren S, Steiner H, et al. 2000. A family of peptidoglycan recognition proteins in the fruit fly Drosophila melanogaster. Proc. Natl. Acad. Sci. USA 97:13772-77
16. Ligoxygakis P, Pelte N, Hoffmann JA, Reichhart JM. 2002. Activation of Drosophila Toll during fungal infection by a blood serine protease. Science 297:114-16
17. Lemaitre B, Kromer-Metzger E, Michaut L, Nicolas E, Meister M, et al. 1995. A recessive mutation, immune deficiency (imd), defines two distinct control pathways in the Drosophila host defense. Proc. Natl. Acad. Sci. USA 92:9465-69
18. Georgel P, Naitza S, Kappler C, Ferrandon D, Zachary D, et al. 2001. Drosophila immune deficiency (IMD) is a death domain protein that activates antibacterial defense and can promote apoptosis. Dev. Cell 1:503-14
19. Silverman N, Zhou R, Stoven S, Pandey N, Hultmark D, et al. 2000. A Drosophila IκB kinase complex required for Relish cleavage and antibacterial immunity. Genes Dev. 14:2461-71
20. Lu Y, Wu LP, Anderson KV. 2001. The antibacterial arm of the Drosophila innate immune response requires an IκB kinase. Genes Dev. 15:104-10
21. Vidal S, Khush RS, Leulier F, Tzou P, Nakamura M, et al. 2001. Mutations in the Drosophila dTAK1 gene reveal a conserved function for MAPKKKs in the control of rel/NF-κB-dependent innate immune responses. Genes Dev. 15:1900-12
22. Rutschmann S, Jung AC, Zhou, R, Silverman N, Hoffmann JA, et al. 2000. Role of Drosophila IKKγ in a toll-independent antibacterial immune response. Nat. Immunol. 1:342-47
23. Williams MJ, Rodriguez A, Kimbrell DA, Eldon ED. 1997. The 18-wheeler mutation reveals complex antibacterial gene regulation in Drosophila host defense. EMBO J. 16:6120-30
24. Khush RS, Leulier F, Lemaitre B. 2001. Drosophila immunity: two paths to NF-κB. Trends Immunol. 22:260-64
25. Tauszig S, Jouanguy E, Hoffmann JA, Imler JL. 2000. Toll-related receptors and the control of antimicrobial peptide expression in Drosophila. Proc. Natl. Acad. Sci. USA 97:10520-25
26. Choe KM, Werner T, Stoven S, Hultmark D, Anderson KV. 2002. Requirement of a peptidoglycan recognition protein (PGRP) in Relish activation and antibacterial immune resonses in Drosophila. Science 296:359-62
27. Gottar M, Gobert V, Michel T, Belvin M, Duyk G, et al. 2002. The Drosophila immune response against Gram-negative bacteria is mediated by a peptidoglycan recognition protein. Nature 416:640-44
28. Ramet M, Manfruelli P, Pearson A, Mathey-Prevota B, Ezekowitz AB. 2002. Functional genomic analysis of phagocytosis and identification of a Drosophila receptor for E. coli. Nature 416:644-48
29. Leulier F, Rodriguez A, Khush RS, Abrams JM, Lemaitre B. 2000. The Drosophila caspase Dredd is required to resist Gram-negative bacterial infection. EMBO Rep. 1:353-58
30. Stoven S, Ando I, Kadalayil L, Engstrom Y, Hultmark D. 2000. Activation of the Drosophila NF-κB factor Relish by rapid endoproteolytic cleavage. EMBO Rep. 1:347-52
31. Ekod-Erickson M, Mishra S, Schneider D. 2000. Interactions between the cellular and humoral immune responses in Drosophila. Curr. Biol. 10:781-84
32. Hu S, Yang X. 2000. dFADD, a novel death domain-containing adapter protein for the Drosophila caspase DREDD. J. Biol. Chem. 275:30761-64
33. Medzhitov R, Preston-Hurlburt P, Janeway CA Jr. 1997. A human homlogue of the Drosophila Toll protein signals activation of adaptive immunity. Nature 388:394-97
34. Rock FL, Hardiman G, Timans JC, Kastelein RA, Bazan JF. 1998. A family of human receptors structurally related to Drosophila Toll. Proc. Natl. Acad. Sci. USA 95:588-93
35. Takeuchi O, Kawai T, Sanjo H, Copeland NG, Gilbert DJ, et al. 1999. TLR6: a novel member of an expanding Toll-like receptor family. Gene 231:59-65
36. Chuang T-H, Ulevitch RJ. 2000. Cloning and characterization of a sub-family of human Toll-like receptors: hTLR7, hTLR8 and hTLR9. Eur. Cytokine Netw. 11:372-78
37. Chuang T-H, Ulevitch RJ. 2001. Identification of hTLR10: a novel human Toll-like receptor preferentially expressed in immune cells. Biochim. Biophys. Acta 1518:157-61
38. Du X, Poltorak A, Wei Y, Beutler B. 2000. Three novel mammalian toll-like receptors: gene structure, expression, and evolution. Eur. Cytokine Netw. 11:362-71
39. Poltorak A, He X, Smirnova I, Liu MY, Huffel CV, et al. 1998. Defective LPS signaling in C3H/HeJ and C57BL/10ScCr mice: mutation in Tlr4 gene. Science 282:2085-88
40. Qureshi ST, Lariviere L, Leveque G, Clermont S, Moore KJ, et al. 1999. Endotoxin-tolerant mice have mutations in Toll-like receptor 4 (Tlr4). J. Exp. Med. 189:615-25
41. Hoshino K, Takeuchi O, Kawai T, Sanjo H, Ogawa T, et al. 1999. Cutting Edge: Toll-like receptor 4 (TLR4)-deficient mice are hyporesponsive to lipopolysaccharide:evidence for TLR4 as the Lps hene product. J. Immunol. 162:3749-52
42. Jiang Q, Akashi S, Miyake K, Petty HR. 2000. Cutting Edge: Lipopolysaccharide induces physical proximity between CD14 and Toll-like receptor 4 (TLR4) prior to nuclear translocation of NF-κB. J. Immunol. 165:3541-44
43. Da Shilva Correia J, Soldau K, Christen U, Tobias PS, Ulevitch J. 2001. Lipopolysaccharide is in close proximity to each of the protein in its membrane receptor complex. J. Biol. Chem. 276:21129-35
44. Shimazu R, Akashi S, Ogata H, Nagai Y, Fukudome K, et al. 1999. MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4. J. Exp. Med. 189:1777-82
45. Akashi S, Shimazu R, Ogata H, Nagai Y, Takeda K, et al. 2000. Cutting Edge: cell surface expression and lipopolysaccharide signaling via the Toll-like receptor 4-MD-2 complex on mouse peritoneal macrophages. J. Immunol. 164:3471-75
46. Schromm AB, Lien E, Henneke P, Chow JC, Yoshimura A, et al. 2001. Molecular genetic analysis of an endotoxin nonresponder mutant cell line: a point mutation in a conserved region of MD-2 abolishes endotoxin-induced signaling. J. Exp. Med. 194:79-88
47. Nagai Y, Akashi S, Nagafuku M, Ogata M, Iwakura Y, et al. 2002. Essential role of MD-2 in LPS responsiveness and TLR4 distribution. Nat. Immunol. 3:667-72
48. Visintin A, Mazzoni A, Spitzer JA, Segal DM. 2001. Secreted MD-2 is a large polymeric protein that efficiently confers lipopolysaccharide sensitivity to Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 98:12156-61
49. Miyake K, Yamashita Y, Ogata M, Sudo T, Kimoto M, 1995. RP105, a novel B cell surface molecule implicated in B cell activation, is a member of the leucine-rich repeat protein family. J. Exp. Med. 154:3333-40
50. Ogata H, Su I, Miyake K, Nagai Y, Akashi S, et al. 2000. The Toll-like receptor protein RP105 regulates lipopolysaccharide signaling in B cells. J. Exp. Med. 192:23-29
51. Byrd-Leifer CA, Block EF, Takeda K, Akira S, Ding A. 2001. The role of MyD88 and TLR4 in the LPS-mimetic activity of Taxol. Eur. J. Immunol. 31:2448-57
52. Kawasaki K, Akashi S, Shimazu R, Yoshida T, Miyake K, et al. 2000. Mouse Toll-like receptor 4-MD-2 complex mediates lipopolysaccharide-mimetic signal transduction by Taxol. J. Biol. Chem. 275:2251-54
53. Kawasaki K, Gomi K, Nishijima M. 2001. Cutting edge: Gln22 of mouse MD-2 is essential for species-specific lipopolysaccharide mimetic action of taxol. J. Immunol. 166:11-14
54. Kurt-Jones EA, Popova L, Kwinn L, Haynes LM, Jones LP, et al. 2000. Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus. Nat. Immunol. 1:398-401
55. Haynes LM, Moore DD, Kurt-Jones EA, Finberg RW, Anderson LJ, et al. 2001. Involvement of Toll-like receptor 4 in innate immunity to respiratory syncytial virus. J. Virol. 75:10730-37
56. Rassa JC, Meyers JL, Zhang Y, Kudaravalli R, Ross SR. 2002. Murine retroviruses activate B cells via interaction with Toll-like receptor 4. Proc. Natl. Acad. Sci. USA 99:2281-86
57. Gallucci S, Matzinger P. 2001. Danger signals: SOS to the immune system. Curr. Opin. Immunol. 13:114-19
58. Ohashi K, Burkart V, Flohe S, Kolb H. 2000. Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex. J. Immunol. 164:558-61
59. Vabulas RM, Ahmad-Nejad P, da Costa C, Miethke T, Kirschning CJ, et al. 2001. Endocytosed HSP60s use toll-like receptor 2 (TLR2) and TLR4 to activate the toll/interleukin-1 receptor signaling pathway in innate immune cells. J. Biol. Chem. 276:31332-39
60. Sasu S, LaVerda D, Qureshi N, Golenbock DT, Beasley D. 2001. Chlamydia pneumoniae and chlamydial heat shock protein 60 stimulate proliferation of human vascular smooth muscle cells via toll-like receptor 4 and p44/p42 mitogen-activated protein kinase activation. Circ. Res. 89:244-50
61. Bulut Y, Fayure E, Thomas L, Karahashi H, Michelsen KS, et al. 2002. Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway. J. Immunol. 168:1435-40
62. Dybdahl B, Wahba A, Lien E, Flo TH, Waage A, et al. 2002. Inflammatory response after open heart surgery: release of heat-shock protein 70 and signaling through toll-like receptor-4. Circulation 105: 685-90
63. Vabulas RM, Ahmad-Nejad P, Ghose S, Kirschning CJ, Issels RD, et al. 2002. HSP70 as endogenous stimulus of toll/interleukin-1 receptor signal pathway. J. Biol. Chem. 277:15107-12
64. Asea A, Rehli M, Kabingu E, Boch JA, Bare O, et al. 2002. Novel signal transduction pathway utilized by extracellular HSP70: role of TLR2 and TLR4. J. Biol. Chem, 277:15028-34
65. Basu S, Binder RJ, Ramalingam T, Srivastava PK. 2001. CD91 is a common receptor for heat shock proteins gp96, hsp90, hsp70, and calreticulin. Immunity 14:303-13
66. Habich C, Baumgart K, Kolb H, Burkart V. 2002. The receptor for heat shock protein 60 on macrophages is saturable, specific, and distinct from receptors for other heat shock proteins. J. Immunol. 168:569-76
67. Okamura Y, Watari M, Jerud ES, Young DW, Ishizaka et al. 2001. The extra domain A of fibronectin activates Toll-like receptor 4. J. Biol. Chem. 276:10229-33
68. Termeer C, Benedix F, Sleeman J, Fieber C, Voith U, et al. 2002. Oligosaccharides of hyaluronan activate dendritic cells via Toll-like receptor 4. J. Exp. Med. 195:99-111
69. Johnson GB, Brunn GJ, Kodaira Y, Platt JL. 2002. Receptor-mediated monitoring of tissue well-being via detection of soluble heparan sulfate by Toll-like receptor 4. J. Immunol. 168:5233-39
70. Smiley ST, King JA, Hancock WW. 2001. Fibrinogen stimulates macrophage chemokine secretion through Toll-like receptor 4. J. Immunol. 167:2887-94
71. Lien E, Means TK, Heine H, Yoshimura A, Kusumoto S, et al. 2000. Toll-like receptor 4 imparts ligand-specific recognition of bacterial lipopolysaccharide. J. Clin. Invest. 105:497-504
72. Poltorak A, Ricciardi-Castagnoli P, Citterio S, Beutler B. 2000. Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation. Proc. Natl. Acad. Sci. USA 97:2163-67
73. Viriyakosol S, Tobias PS, Kitchens RL, Kirkland TN. 2001. MD-2 binds to bacterial lipopolysaccharide. J. Biol. Chem. 276:38044-51
74. Akashi S, Nagai Y, Ogata H, Oikawa M, Fukase K, et al. 2001. Human MD-2 confers on mouse Toll-like receptor 4 species-specific lipopolysaccharide recognition. Int. Immunol. 13:1595-99
75. Hajjar AM, Ernst RK, Tsai JH, Wilson CB, Miller SI. 2002. Human Toll-like receptor 4 recognizes host-specific LPS modifications. Nat. Immunol. 3:354-59
76. Triantafilou K, Triantafilou M, Dedrick RL. 2001. A CD14-independent LPS receptor cluster. Nat. Immunol. 2:338-45
77. Detmers PA, Thieblemont N, Vasselon T, Pironkova R, Miller DS, et al. 1996. Potential role of membrane internalization and vesicle fusion in adhesion of neutrophils in response to lipopolysaccharide and TNF. J. Immunol. 157:5589-96
78. Inohara N, Koseki T, del Peso L, Hu Y, Yee C, et al. 1999. Nod1, an Apaf-1-like activator of caspase-9 and nuclear factor-κB. J. Biol. Chem. 274:14560-67
79. Inohara N, Ogura Y, Chen FF, Muto A, Nunez G. 2001. Human Nod1 confers responsiveness to bacterial lipopolysaccharides. J. Biol. Chem. 276:2551-54
80. Girardin SE, Tournebize R, Mavris M, Page AL, Li X, et al. 2001. CARD4/Nod1 mediates NF-κB and JNK activation by invasive Shigella flexneri. EMBO Rep. 2:736-42
81. Hugot JP, Chamaillard M, Zouali H, Lesage S, Cezard JP, et al. 2001. Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease. Nature 411:599-603
82. Ogura Y, Bonen DK, Inohara N, Nicolae DL, Chen FF, et al. 2001. A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease. Nature 411:603-6
83. Aliprantis AO, Yang RB, Mark MR, Suggett S, Devaux B, et al. 1999. Cell activation and apoptosis by bacterial lipoproteins through Toll-like receptor 2. Science 285:736-39
84. Aliprantis AO, Yang RB, Weiss DS, Godowski P, Zychlinsky A. 2000. The apoptotic signaling pathway activated by Toll-like receptor. EMBO J. 19:3325-36
85. Brightbill HD, Libraty DH, Krutzik SR, Yang R-B, Belisle JT, et al. 1999. Host defense mechanisms triggered by microbial lipoproteins through Toll-like receptors. Science 285:732-36
86. Lien E, Sellati TJ, Yoshimura A, Flo TH, Rawadi G, et al. 1999. Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products. J. Biol. Chem. 274:33419-25
87. Hirschfeld M, Kirschning CJ, Schwandner R, Wesche H, Weis JH, et al. 1999. Cutting Edge: Inflammatory signaling by Borrelia burgdorferi lipoproteins is mediated by Toll-like receptor 2. J. Immunol. 163:2382-86
88. Schwadner R, Dziarski R, Wesche H, Rothe M, Kirschning CJ. 1999. Peptidoglycan- and lipoteichoic acid-induced cell activation is mediated by Toll-like receptor 2. J. Biol. Chem. 274:17406-9
89. Yoshimura A, Lien E, Ingalls RR, Tuomanen E, Dziarski R, et al. 1999. Cutting Edge: Recognition of Gram-positive bacterial cell wall components by the innate immune system occurs via Toll-like receptor 2. J. Immunol. 165:1-5
90. Underhill DM, Ozinsky A, Smith KD, Aderem A. 1999. Toll-like receptor 2 mediates mycobacteria-induced proinflammatory signaling in macrophages. Proc. Natl. Acad. Sci. USA 96:14459-63
91. Lehner MD, Morath S, Michelsen KS, Schumann RR, Hartung T 2001. Induction of cross-tolerance by lipopolysaccharide and highly purified lipoteichoic acid via different toll-like receptors independent of paracrine mediators. J. Immunol. 166:5161-67
92. Means TK, Wang S, Lien E, Yoshimura A, Golenbock DT, et al. 1999. Human Toll-like receptors mediate cellular activation by Mycobacterium tuberculosis. J. Immunol. 163:3920-27
93. Means TK, Lien E, Yoshimura A, Wang S, Golenbock DT, et al. 1999. The CD14 ligands lipoarabinomannan and lipopolysaccharide differ in their requirement for Toll-like receptors. J. Immunol. 163:6748-55
94. Campos MA, Almeida IC, Takeuchi O, Akira S, Valente EP, et al. 2001. Activation of Toll-like receptor-2 by glycosylphosphatidylinositol anchors from a protozoan parasite. J. Immunol. 167:416-23
95. Hajjar AM, O'Mahony DS, Ozinsky A, Underhill DM, Aderem A, et al. 2001. Cutting Edge: Functional interactions between Toll-like receptor (TLR) 2 and TLR1 or TLR6 in response to phenol-soluble modulin. J. Immunol. 166:15-19
96. Underhill DM, Ozinsky A, Hajjar AM, Stevens A, Wilson CB, et al. 1999. The Toll-like receptor 2 is recruited to macrophage phagosomes and discriminates between pathogens. Nature 401:811-15
97. Opitz B, Schroder NW, Spreitzer I, Michelsen KS, Kirschning CJ, et al. 2001. Toll-like receptor-2 mediates Treponema glycolipid and lipoteichoic acid-induced NF-κB translocation. J. Biol. Chem. 276:22041-47
98. Massari P, Henneke P, Ho Y, Latz E, Golenbock DT, et al. 2002. Cutting edge: Immune stimulation by Neisserial porins is Toll-like receptor 2 and MyD88 dependent. J. Immunol. 168:1533-37
99. Takeuchi O, Hoshino K, Kawai T, Sanjo H, Takada H, et al. 1999. Differential roles of TLR2 and TLR4 in recognition of Gram-negative and Gram-positive cell wall components. Immunity 11:443-51
100. Takeuchi O, Kaufmann A, Grote K, Kawai T, Hoshino K, et al. 2000. Cutting Edge: Preferentially the R-stereoisomer of the Mycoplasmal lipopeptide macrophage-activating lipopeptide-2 activates immune cells through a Toll-like receptor 2- and MyD88-dependent signaling pathway. J. Immunol. 164:554-57
101. Takeuchi O, Hoshino K, Akira S. 2000. Cutting Edge: TLR2-deficient and MyD88-deficient mice are highly susceptible to Staphylococcus aureus infection. J. Immunol. 165:5392-96
102. Wooten RM, Ma Y, Yoder RA, Brown JP, Weis JH, et al. 2002. Toll-like receptor 2 is required for innate, but not acquired, host defense to Borrelia burgdorferi. J. Immunol. 168:348-55
103. Hirschfeld M, Weis JJ, Toshchakov V, Salkowski CA, Cody MJ, et al. 2001. Signaling by Toll-like receptor 2 and 4 agonists results in differential gene expression in murine macrophages. Infect. Immun. 69:1477-82
104. Werts C, Tapping RI, Mathison JC, Chuang T-H, Kravchenko V, et al. 2001. Leptospiral lipopolysaccharide activates cells through a TLR2-dependent mechanism. Nat. Immunol. 2:346-52
105. Netea MG, van Deuren M, Kullberg BJ, Cavaillon JM, Van der Maer WM. 2002. Does the shape of lipid A determine the interaction of LPS with Toll-like receptors? Trends Immunol. 23:135-39
106. Ozinsky A, Underhill DM, Fontenot JD, Hajjar AM, Smith KD, et al. 2000. The repertoire for pattern recognition of pathogens by the innate immune system is defined by cooperation between Toll-like receptors. Proc. Natl. Acad. Sci. USA 97:13766-71
107. Takeuchi O, Kawai T, Muhlradt PF, Radolf JD, Zychlinsky A, et al. 2001. Discrimination of bacterial lipopeptides by Toll-like receptor 6. Int. Immunol. 13:933-40
108. Wyllie DH, Kiss-Toth E, Visintin A, Smith SC, Boussouf S, et al. 2000. Evidence for an accessory protein function for Toll-like receptor 1 in anti-bacterial responses. J. Immunol. 165:7125-32
109. Takeuchi O, Horiuchi T, Hoshino K, Takeda K, Dong Z, et al. 2002. Role of TLR1 in mediating immune response to microbial lipoproteins. J. Immunol. 169:10-14
110. Alexopoulou L, Thomas V, Schnare M, Lobet Y, Anguita J, et al. 2002. Hyporesponsiveness to vaccination with Borrelia burgdorferi OspA in humans and in TLR1- and TLR2-deficient mice. Nat. Med. 8:878-84
111. Hayashi F, Smith KD, Ozinsky A, Hawn TR, Yi EC, et al. 2001. The innate immune response to bacterial flagellin is mediated by Toll-like receptor-5. Nature 410:1099-103
112. Eaves-Pyles TD, Wong HR, Odoms K, Pyles RB. 2001. Salmonella flagellin-dependent proinflammatory responses are localized to the conserved amino and carboxyl regions of the protein. J. Immunol. 167:7009-16
113. Gomez-Gomez L, Boller T. 2000. FLS2: an LRR receptor-like kinase involved in the perception of the bacterial elicitor flagellin in Arabidopsis. Mol. Cell 5:1003-11
114. Baker B, Zambryski P, Staskawicz B, Dinesh-Kumar SP. 1997. Signaling in plant-microbe interactions. Science 276:726-33
115. Asai T, Tena G, Plotnikova J, Willmann MR, Chiu W-L, et al. 2002. MAP kinase signaling cascade in Arabidopsis innate immunity. Nature 415:977-83
116. Yang Y-L, Reis LFL, Pavlovic J, Aguzzi A, Schaefer R, et al. 1995. Deficient signalling in mice devoid of double-stranded RNA-dependent protein kinase. EMBO J. 14:6095-106
117. Chu W-M, Ostertag D, Li Z-W, Chang L, Chen Y, et al. 1999. JNK2 and IKK are required for activating the innate response to viral infection. Immunity 11:721-31
118. Balachandran S, Roberts PC, Brown LE, Truong H, Pattnaik AK, et al. 2000. Essential role for the dsRNA-dependent protein kinase PKR in innate immunity to viral infection. Immunity 13:129-41
119. Levy DE. 2002. Whence interferone? Variety in the production of interferon in response to viral infection. J. Exp. Med. 195:F15-18
120. Alexopoulou L, Holt AC, Medzhitov R, Flavell RA. 2001. Recognition of double-stranded RNA and activation of NF-κB by Toll-like receptor 3. Nature 413:732-38
121. Siegal FP, Kadowaki N, Shodell M, Fitzgerald-Bocarsly PA, Shah K, et al. 1999. The nature of the principal type 1 interferon-producing cells in human blood. Science 284:1835-37
122. Asselin-Paturel C, Boonstra A, Dalod M, Durand I, Yessaad N, et al. 2001. Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat. Immunol. 2:1144-50
123. 1+ cells in mouse lymph nodes and spleen display characteristics of plasmacytoid dendritic cells. J. Exp. Med. 194:1171-78
124. Kadowaki N, Ho S, Antonenko S, Malefyt RW, Kastelein RA, et al. 2001. Subsets of human dendritic cell precursors express different Toll-like receptors and respond to different microbial antigens. J. Exp. Med. 194:863-69
125. Muzio M, Bosisio D, Polentarutti N, D'Amico G, Stoppacciaro A, et al. 2000. Differential expression and regulation of Toll-like receptors (TLR) in human leukocytes: selective expression of TLR3 in dendritic cells. J. Immunol. 164:5998-6004
126. Hemmi H, Takeuchi O, Kawai T, Kaisho T, Sato S, et al. 2000. A Toll-like receptor recognizes bacterial DNA. Nature 408:740-45
127. Elkins KL, Rhinehart-Jones TR, Stibitz S, Conover JS, Klinman DM. 1999. Bacterial DNA containing CpG motifs stimulates lymphocyte-dependent protection of mice against lethal infection with intracellular bacteria. J. Immunol. 162:2291-98
128. Krieg AM, Love-Homan L, Yi A-K, Harty JT. 1998. CpG DNA induces sustained IL-12 expression in vivo and resistance to Listeria monocytogenes challenge. J. Immunol. 161:2428-34
129. Zimmermann S, Egeter O, Hausmann S, Lipford GB, Rocken M, et al. 1998. CpG oligodeoxynucleotides trigger protective and curative Th1 responses in lethal murine leishmaniasis. J. Immunol. 160:3627-30
130. Wagner H. 1999. Bacterial CpG DNA activates immune cells to signal infectious danger. Adv. Immunol. 73:329-67
131. Wagner H. 2001. Toll meets bacterial CpG-DNA. Immunity 14:499-502
132. Krieg AM, Wagner H. 2000. Causing a commotion in the blood: immunotherapy progresses from bacteria to bacterial DNA. Immunol. Today 21:521-26
133. Bauer S, Kirschning CJ, Hacker H, Redecke V, Hausmann S, et al. 2001. Human TLR9 confers responsiveness to bacterial DNA via species-specific CpG motif recognition. Proc. Natl. Acad. Sci. USA 98:9237-42
134. Ahmad-Nejad P, Hacker H, Rutz M, Bauer S, Vabulas RM, et al. 2002. Bacterial CpG-DNA and lipopolysaccharides activate Toll-like receptors at distinct cellular compartments. Eur. J. Immunol. 32:1958-68
135. Yang R-B, Mark MR, Gurney AL, Godowski PJ. 1999. Signaling events induced by lipopolysaccharide-activated Toll-like receptor 2. J. Immunol. 163:639-43
136. Visintin A, Mazzoni A, Spitzer JH, Wyllie DH, Dower SK, et al. Regulation of Toll-like receptors in human monocytes and dendritic cells. J. Immunol. 166:249-55
137. Hemmi H, Kaisho T, Takeuchi O, Sato S, Sanjo S, et al. 2002. Small antiviral compounds activate immune cells via TLR7 MyD88-dependent signalling pathway. Nat. Immunol. 3:196-200
138. Goodman MG. 1995. A new approach to vaccine adjuvants. Immunopotentiation by intracellular T-helper-like signals transmitted by loxoribine. Pharm. Biotechnol. 6:581-609
139. Sarosdy MF. 1993. Bropirimine in bladder cancer: clinical studies. Ann. NY Acad. Sci. 685:301-8
140. Krug A, Towarowski A, Britsch S, Rothenfusser S, Hornung V, et al. 2001. Toll-like receptor expression reveals CpG DNA as a unique microbial stimulus for plasmacytoid dendritic cells which synergizes with CD40 ligand to induce high amounts of IL-12. Eur. J. Immunol. 31:3026-37
141. Rissoan M-C, Soumelis V, Kadowaki N, Grouard G, Briere F, et al. 1999. Reciprocal control of T helper cell and dendritic cell differentiation. Science 283:1183-86
142. Liu YJ, Kanzler H, Soumelis V, Gilliet M. 2001. Dendritic cells, plasticity and cross-regulation. Nat. Immunol. 2:585-89
143. Liu YJ. 2001. Dendritic cell subsets and lineages, and their functions in innate and adaptive immunity. Cell 106:259-62
144. Jarrossay D, Napolitani G, Colonna M, Sallusto F, Lanzavecchia A. 2001. Specialization and complementarity in microbial molecule recognition by human myeloid and plasmacytoid dendritic cells. Eur. J. Immunol. 31:3388-93
145. Ito T, Amakawa R, Kaisho T, Hemmi H, Tajima K, et al. 2002. Interferon-α and interleukin-12 are induced differentially by Toll-like receptor 7 ligands in human blood dendritic cell subsets. J. Exp. Med. 195:1507-12
146. Mellman I, Steinman RM. 2001. Dendritic cells: specialized and regulated antigen processing machines. Cell 106:255-58
147. Tsuji S, Matsumoto M, Takeuchi O, Akira S, Azuma I, et al. 2000. Maturation of human dendritic cells by cell wall skeleton of Mycobacterium bovis Calmette-Guerin: involvement of toll-like receptors. Infect. Immun. 68:6883-90
148. Hertz CJ, Kiertscher SM, Godowski PJ, Bouis DA, Norgard MV, et al. 2001. Microbial lipopeptides stimulate dendritic cell maturation via Toll-like receptor 2. J. Immunol. 166:2444-50
149. Michelsen KS, Aicher A, Mohaupt M, Hartung T, Dimmeler S, et al. 2001. The role of Toll-like receptors (TLRs) in bacteria-induced maturation of murine dendritic cells (DCs): peptidoglycan and lipoteichoic acid are inducers of DC maturation and require TLR2. J. Biol. Chem. 276:25680-86
150. Zarember KA, Godowski PJ. 2002. Tissue expression of human Toll-like receptors and differential regulation of Toll-like receptor mRNAs in leukocytes in response to microbes, their products, and cytokines. J. Immunol. 168:554-61
151. Malaviya R, Abraham SN. 2001. Mast cell modulation of immune responses to bacteria. Immunol. Rev. 179:16-24
152. Supajatura V, Ushio H, Nakao A, Okumura K, Ra C, et al. 2001. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4. J. Immunol. 167:2250-56
153. McCurdy JD, Lin TJ, Marshall JS. 2001. Toll-like receptor 4-mediated activation of murine mast cells. J. Leukoc. Biol. 70:977-84
154. Supajatura V, Ushio H, Nakao A, Akira S, Okumura K, et al. 2002. Differential responses of mast cell Toll-like receptors 2 and 4 in allergy and innate immunity. J. Clin. Invest. 109:1351-59
155. Gewirtz AT, Navas TA, Lyons S, Godowski PJ, Madara JL. 2001. Cutting edge: bacterial flagellin activates basolaterally expressed TLR5 to induce epithelial proinflammatory gene expression. J. Immunol. 167:1882-85
156. Abreu MT, Vora P, Faure E, Thomas LS, Arnold ET, et al. 2001. Decreased expression of Toll-like receptor-4 and MD-2 correlates with intestinal epithelial cell protection against dysregulated proinflammatory gene expression in response to bacterial lipopolysaccharide. J. Immunol. 167:1609-16
157. Naik S, Kelly EJ, Meijer L, Pettersson S, Sanderson IR. 2001. Absence of Toll-like receptor 4 explains endotoxin hyporesponsiveness in human intestinal epithelium. J. Pediatr. Gastroenterol. Nutr. 32:449-53
158. Cario E, Podolsky DK. 2000. Differential alteration in intestinal epithelial cell expression of Toll-like receptor 3 (TLR3) and TLR4 in inflammatory bowel disease. Infect. Immun. 68:7010-17
159. Hornef MW, Frisan T, Vandewalle A, Normark S, Richter-Dahlfors A. 2002. Toll-like receptor 4 resides in the Golgi apparatus and colocalizes with internalized lipopolysaccharide in intestinal epithelial cells. J. Exp. Med. 195:559-70
160. Thieblemont N, Wright SD. 1999. Transport of bacterial lipopolysaccharide to the Golgi apparatus. J. Exp. Med. 190:523-34
161. Wolfs TG, Buurman WA, van Schadewijk A, de Vries B, Daemen MA, et al. 2002. In vivo expression of Toll-like receptor 2 and 4 by renal epithelial cells: IFN-γ and TNF-α mediated up-regulation during inflammation. J. Immunol. 168:1286-93
162. Wang X, Moser C, Louboutin JP, Lysenko ES, Weiner DJ, et al. 2002. Toll-like receptor 4 mediates innate immune responses to Haemophilus influenzae infection in mouse lung. J. Immunol. 168:810-15
163. Andre AS, Blackwell NM, Hall LR, Hoerauf A, Brattig NW, et al. 2002. The role of endosymbiotic Wolbachia bacteria in the pathogensis of river blindness. Science 295:1892-95
164. Faure E, Equils O, Siding PA, Thomas L, Zhang FX, et al. 2000. Bacterial lipopolysaccharide activates NF-κB through Toll-like receptor 4 (TLR-4) in cultured human dermal endothelial cells. Differential expression of TLR-4 and TLR-2 in endothelial cells. J. Biol. Chem. 275:11058-63
165. Wang T, Laufuse WP, Zwilling BS. 2000. Regulation of Toll-like receptor 2 expression by macrophages following Mycobacterium avium infection. J. Immunol. 165:6308-13
166. Wang T, Lafuse WP, Zwilling BS. 2001. NF-κB and Sp1 elements are necessary for maximal transcription of Toll-like receptor 2 induced by Mycobacterium avium. J. Immunol. 167:6924-32
167. Wang T, Lafuse WP, Takeda K, Akira S, Zwilling BS. 2002. Rapid chromatin remodeling of Toll-like receptor 2 promoter during infection of macrophages with Mycobacterium avium. J. Immunol. 169:795-801
168. Shuto T, Xu H, Wang B, Han J, Kai H, et al. 2001. Activation of NF-κB by nontypeable Hemophilus influenzae is mediated by Toll-like receptor 2-TAK1-dependent NIK-IKKα/β-IκBα and MKK3/6-p38 MAP kinase signaling pathways in epithelial cells. Proc. Natl. Acad. Sci. USA 98:8774-79
169. Shuto T, Imasato A, Jono H, Sakai A, Xu H, et al. 2002. Glucocorticoids synergistically enhance nontypeable Haemophilus influenzae-induced Toll-like receptor 2 expression via a negative cross-talk with p38 MAP kinase. J. Biol. Chem. 277:17263-70
170. Mokuno Y, Matsuguchi T, Takano M, Nishimura H, Washizu J, et al. 2000. Expression of Toll-like receptor 2 on γδ T cells bearing invariant Vγ6/Vδ1 induced by Escherichia coli infection in mice. J. Immunol. 165:931-40
171. Miettinen M, Sareneva T, Julkunen I, Matikainen S. 2001. IFNs activate Toll-like receptor gene expression in viral infections. Genes Immun. 2:349-55
172. Matsuguchi T, Musikacharoen T, Ogawa T, Yoshikai Y. 2000. Gene expressions of Toll-like receptor 2, but not Toll-like receptor 4, is induced
173. Lin Y, Lee H, Berg AH, Lisanti MP, Shapiro L, et al. 2000. The lipopolysaccharide-activated Toll-like receptor (TLR)-4 induces synthesis of the closely related receptor TLR-2 in adipocytes. J. Biol. Chem. 275:24255-63
174. Nomura F, Akashi S, Sakao Y, Sato S, Kawai T, et al. 2000. Endotoxin tolerance in mouse peritoneal macrophages correlates with downregulation of surface Toll-like receptor 4 expression. J. Immunol. 164:3476-79
175. Sweet MJ, Campbell CC, Sester DP, Xu D, McDonald RC, et al. 2002. Colony-stimulating factor-1 suppresses responses to CpG DNA and expression of toll-like receptor 9 but enhances responses to lipopolysaccharide in murine macrophages. J. Immunol. 168:392-99
176. Bozza M, Satoskar AR, Lin G, Lu B, Humbles AA, et al. 1999. Targeted disruption of migration inhibitory factor gene reveals its critical role in sepsis. J. Exp. Med. 189:341-46
177. Roger T, David J, Glauser MP, Calandra T. 2001. MIF regulates innate immune responses through modulation of Toll-like receptor 4. Nature 414:920-24
178. Bosisio D, Polentarutti N, Sironi M, Bernasconi S, Miyake K, et al. 2002. Stimulation of Toll-like receptor 4 expression in human mononuclear phagocytes by interferon-gamma: a molecular basis for priming and synergism with bacterial lipopolysaccharide. Blood 99:3427-31
179. Musikacharoen T, Matsuguchi T, Kikuchi T, Yoshikai Y. 2001. NF-κB and STAT5 play important roles in the regulation of mouse Toll-like receptor 2 gene expression. J. Immunol. 166:4516-24
180. Sweet MJ, Leung BP, Kang D, Sogaard M, Schulz K, et al. 2001. A novel pathway regulating lipopolysaccharide-induced shock by ST2/T1 via inhibition of Toll-Like receptor 4 expression. J. Immunol. 166:6633-39
181. Muzio M, Ni J, Feng P, Dixit VM. 1997. IRAK (Pelle) family member IRAK-2 and MyD88 as proximal mediators of IL-1 signaling. Science 278:1612-15
182. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A. 1998. The human Toll signaling pathway: divergence of nuclear factor κB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J. Exp. Med. 187:2097-101
183. Wesche H, Henzel WJ, Shillinglaw W, Li S, Cao Z. 1997. MyD88: an adaptor protein that recruits IRAK to the IL-1 receptor complex. Immunity 7:837-47
184. Burnsm K, Martinon F, Esslinger C, Pahl H, Schneider P, et al. 1998. MyD88, an adaptor protein involved in interleukin-1 signaling. J. Biol. Chem. 273:12203-9
185. Medzhitov R, Preston-Hurlburt P, Kopp E, Stadlen A, Chen C, et al. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Mol. Cell 2:253-58
186. Adachi O, Kawai T, Takeda K, Matsumoto M, Tsutsui H, et al. 1998. Targeted disruption of the MyD88 gene results in loss of IL-1-and IL-18-mediated function. Immunity 9:143-50
187. Kawai T, Adachi O, Ogawa T, Takeda K, Akira S. 1999. Unresponsiveness of MyD88-deficient mice to endotoxin. Immunity 11:115-22
188. Takeuchi O, Takeda K, Hoshin K, Adachi O, Ogawa T, et al. 2000. Cellular responses to bacterial cell wall components are mediated through MyD88-dependent signaling cascades. Int. Immunol. 12:113-17
189. Hacker H, Vabulas RM, Takeuchi O, Hoshino K, Akira S, et al. 2000. Immune cell activation by bacterial CpG-DNA through myeloid differentiation marker 88 and tumor necrosis factor receptor-associated factor (TRAF)6. J. Exp. Med. 192:595-600
190. Schnare M, Holt AC, Takeda K, Akira S, Medzhitov R. 2000. Recognition of CpG DNA is mediated by signaling pathways dependent on the adaptor protein MyD88. Curr. Biol. 10:1139-42
191. Lomaga MA, Yeh WC, Sarosi I, Duncan GS, Furlonger C, et al. 1999. TRAF6 deficiency results in osteopetrosis and defective interleukin- 1, CD40, and LPS signaling. Genes Dev. 13:1015-24
192. Naito A, Azuma S, Tanaka S, Miyazaki T, Takaki S, et al. 1999. Severe osteopetrosis, defective interleukin-1 signalling and lymph node organogenesis in TRAF6-deficient mice. Genes Cells 4:353-62
193. Li S, Strelow A, Fontana EJ, Wesche H. 2002. IRAK-4 - a novel member of the IRAK family with the properties of an IRAK-kinase. Proc. Natl. Acad. Sci. USA 99:5567-72
194. Kanakaraj P, Ngo K, Wu Y, Angulo A, Ghazal P, et al. 1998. Defective interleukin (IL)-18-mediated natural killer and T helper cell type 1 responses in IL-1 receptor-associated kinase (IRAK)-deficient mice. J. Exp. Med. 187:2073-79
195. Thomas JA, Allen JL, Tsen M, Dubnicoff T, Danao J, et al. 1999. Impaired cytokine signaling in mice lacking the IL-1 receptor-associated kinase. J. Immunol. 163:978-84
196. Swantek JL, Tsen MF, Cobb MH, Thomas JA. 2000. IL-1 receptor-associated kinase modulates host responsiveness to endotoxin. J. Immunol. 164:4301-6
197. Suzuki N, Suzuki S, Duncan GS, Millar DG, Wada T, et al. 2002. Severe impairment of interleukin-1 and Toll-like receptor signaling in mice lacking IRAK-4. Nature 416:750-56
198. O'Connell MA, Bennett BL, Mercurio F, Manning AM, Mackman N. 1998. Role of IKK1 and IKK2 in lipopolysaccharide signaling in human monocytic cells. J. Biol. Chem. 273:30410-14
199. Fischer C, Page S, Weber M, Eisele T, Neumeier D, et al. 1999. Differential effects of lipopolysaccharide and tumor necrosis factor on monocytic IκB kinase signalsome activation and IκB proteolysis. J. Biol. Chem. 274:24625
200. Rudolph D, Yeh WC, Wakeham A, Rudolph B, Nallainathan D, et al. 2000. Severe liver degeneration and lack of NF-κB activation in NEMO/IKKγ-deficient mice. Genes Dev. 14:854-62
201. Ninomiya-Tsuji J, Kishimoto K, Hiyama A, Inoue J, Cao Z, et al. 1999. The kinase TAK1 can activate the NIK-IκB as well as the MAP kinase cascade in the IL-1 signalling pathway. Nature 398:252-56
202. Irie T, Muta T, Takeshige K. 2000. TAK1 mediates an activation signal from toll-like receptor(s) to nuclear factor-κB in lipopolysaccharide-stimulated macrophages. FEBS Lett. 467:160-64
203. Lee J, Mira-Arbibe L, Ulevitc RJ. 2000. TAK1 regulates multiple protein kinase cascades activated by bacterial lipopolysaccharide. J. Leukoc. Biol. 68:909-15
204. Deng L, Wang C, Spencer E, Yang L, Braun A, et al. 2000. Activation of the IκB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103:351-61
205. Wang C, Deng L, Hong M, Akkaraju GR, Inoue J, et al. 2001. TAK1 is a ubiquitin-dependent kinase of MKK and IKK. Nature 412:346-51
206. Kopp E, Medzhitov R, Carothers J, Xiao C, Douglas I, et al. 1999. ECSIT is an evolutionarily conserved intermediate in the Toll/IL-1 signal transduction pathway. Genes Dev. 13:2059-71
207. McCarthy JV, Ni J, Dixit VM. 1998. RIP2 is a novel NF-κ B-activating and cell death-inducing kinase. J. Biol. Chem. 273:16968-75
208. Inohara N, del Peso L, Koseki T, Chen S, Nunez G. 1998. RICK, a novel protein kinase containing a caspase recruitment domain, interacts with CLARP and regulates CD95-mediated apoptosis. J. Biol. Chem. 273:12296-300
209. Kobayashi K, Inohara N, Hernandez LD, Galan JE, Nunez G, et al. 2002. RICK/Rip2/CARDIAK mediates signaling for receptors of the innate and adaptive immune systems. Nature 416:194-99
210. Chin AI, Dempsey PW, Bruhn K, Miller JF, Xu Y, et al. 2002. Involvement of receptor-interacting protein 2 in innate and adaptive immune responses. Nature 416:190-94
211. Kaisho T, Akira S. 2001. Dendritic-cell function in Toll-like receptor and MyD88-knockout mice. Trends Immunol. 22:78-83
212. Kaisho T, Takeuchi O, Kawai T, Hoshino K, Akira S. 2001. Endotoxin-induced maturation of MyD88-deficient dendritic cells. J. Immunol. 166:5688-94
213. Seki E, Tsutsui H, Nakano H, Tsuji N, Hoshino K, et al. 2001. Lipopolysaccharide-induced IL-18 secretion from murine Kupffer cells independently of myeloid differentiation factor 88 that is critically involved in induction of production of IL-12 and IL-1β. J. Immunol. 166:2651-57
214. Kawai T, Takeuchi O, Fujita T, Inoue J, Muhlradt PF, et al. 2001. Lipopolysaccharide stimulates the MyD88-independent pathway and results in activation of IRF-3 and the expression of a subset of LPS-inducible genes. J. Immunol. 167:5887-94
215. Horng T, Barton GM, Medzhitov R. 2001. TIRAP: an adapter molecule in the Toll signaling pathway. Nat. Immunol. 2:835-41
216. Fitzgerald KA, Palsson-McDermott EM, Bowie AG, Jefferies C, Mansell AS, et al. 2001. Mal (MyD88-adaptor-like) is required for Toll-like receptor-4 signal transduction. Nature 413:78-83
217. Malakhov O, Malakhov M, Hetherington C, Zhang D-E. 2002. Lipopolysaccharide activates the expression of ISG15 specific protease-UBP43 via interferon regulatory factor 3. J. Biol. Chem. 277:14703-11
218. Sato M, Suemori H, Hata N, Asagiri M, Ogasawara K, et al. 2000. Distinct and essential roles of transcription factors IRF-3 and IRF-7 in response to viruses for IFN-α/β gene induction. Immunity 13:539-48
219. Iwamura T, Yoneyama M, Yamaguchi K, Suhara W, Mori W, et al. 2001. Induction of IRF-3/-7 kinase and NF-κB in response to double-stranded RNA and virus infection: common and unique pathways. Genes Cells 6:375-88
220. Taniguchi T, Takaoka A. 2002. The interferon-αβ system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr. Opin. Immunol. 14:111-16
221. Arbibe L, Mira JP, Teusch N, Kline L, Guha M, et al. 2000. Toll-like receptor 2-mediated NF-κB activation requires a Rac1-dependent pathway. Nat. Immunol. 1:533-40
222. Re F, Strominger JL. 2001. Toll-like receptor 2 (TLR2) and TLR4 differentially activate human dendritic cells. J. Biol. Chem. 276:37692-99
223. Burns K, Clatworthy J, Martin L, Martinon F, Plumpton C, et al. 2000. Tollip, a new component of the IL-1RI pathway, links IRAK to the IL-1 receptor. Nat. Cell Biol. 2:346-51
224. Bulut Y, Faure E, Thomas L, Equils O, Arditi M. 2002. Cooperation of Toll-like receptor 2 and 6 for cellular activation by soluble tuberculosis factor and Borrelia burgdorferi outer surface protein A lipoprotein: role of Toll-interacting protein and IL-1 receptor signaling molecules in Toll-like receptor 2 signaling. J. Immunol. 167:987-94
225. Zhang G, Ghosh S. 2002. Negative regulation of toll-like receptor-mediated signaling by Tollip. J. Biol. Chem. 77:7059-65
226. Ghosh S, May MJ, Kopp EB. 1998. NF-κB and Re1 proteins: evolutionarily conserved mediators of immune responses. Annu. Rev. Immunol. 16:225-60
227. Sha WC, Liou H-C, Tuomanen EI, Baltimore D. 1995. Targeted disruption of the p50 subunit of NF-κB leads to multifocal defects in immune responses. Cell 80:321-30
228. Caamano J, Alexander J, Craig L, Bravo R, Hunter CA. 1999. The NF-κB family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J. Immunol. 163:4453-61
229. Franzoso G, Carlson L, Poljak L, Shores EW, Epstein S, et al. 1998. Mice deficient in nuclear factor (NF)-κB/p52 present with defects in humoral responses, germinal center reactions, and splenic microarchitecture. J. Exp. Med. 187:147-59
230. Burkly L, Hession C, Ogata L, Reilly C, Marconi LA, et al. 1995. Expression of relB is required for the development of thymic medulla and dendritic cells. Nature 373:531-36
231. Weih F, Carrasco D, Durham SK, Barton DS, Rizzo CA, et al. 1995. Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-κB/Rel family. Cell 80:331-40
232. + dendritic cells. Immunity 9:839-47
233. Ouaaz F, Arron J, Zheng Y, Choi Y, Beg AA. 2002. Dendritic cell development and survival require distinct NF-κB subunits. Immunity 16:257-70
234. Li M, Carpio DF, Zheng Y, Bruzzo P, Singh V, et al. 2001. An essential role of the NF-κB/Toll-like receptor pathway in induction of inflammatory and tissue-repair gene expression by necrotic cells. J. Immunol. 166:7128-35
235. Karin M, Liu Z, Zandi E. 1997. AP-1 function and regulation. Curr. Opin. Cell Biol. 9:240-46
236. Karin M. 1995. The regulation of AP-1 activity by mitogen-activated protein kinases. J. Biol Chem. 270:16483-86
237. Mackman N, Brand K, Edgington TS. 1991. Lipopolysaccharide-mediated transcriptional activation of the human tissue factor gene in THP-1 monocytic cells requires both activator protein 1 and nuclear factor κB binding sites. J. Exp. Med. 174:1517-26
238. Yao J, Mackman N, Edgington TS, Fan ST. 1997. Lipopolysaccharide induction of the tumor necrosis factor-α promoter in human monocytic cells. Regulation by Egr-1, c-Jun, and NF-κB transcription factors. J. Biol. Chem. 272:17795-801
239. Gupta D, Wang Q, Vinson C, Dziarski R. 1999. Bacterial peptidoglycan induces CD14-dependent activation of transcription factors CREB/ATF and AP-1. J. Biol. Chem. 274:14012-20
240. Akira S, Kishimoto T. 1997. NF-IL6 and NF-κB in cytokine gene regulation. Adv. Immunol. 65:1-46
241. Akira S, Isshiki H, Sugita T, Tanabe O, Kinoshita S, et al. 1990. A nuclear factor for IL-6 expression (NF-IL6) is a member of a C/EBP family. EMBO J. 9:1897-906
242. Poli V. 1999. The role of C/EBP isoforms in the control of inflammatory and native immunity functions. J. Biol. Chem. 273:29279-82
243. Tanaka T, Akira S, Yoshida K, Umemoto M, Yoneda Y, et al. 1995. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 80:353-61
244. Gorgoni B, Caivano M, Arizmendi C, Poli V. 2001. The transcription factor C/EBPβ is essential for inducible expression of the cox-2 gene in macrophages but not in fibroblasts. J. Biol. Chem. 276:4.0769-77
245. Matsumoto M, Tanaka T, Kaisho T, Sanjo H, Copeland NG, et al. 1999. A novel LPS-inducible C-type lectin is a transcriptional target of NF-IL6 in macrophages. J. Immunol. 163:5039-48
246. 2 synthase gene induced by the Toll-like receptor 4/MyD88/NF-IL6 pathway. J. Immunol. 168:5811-16
247. Taniguchi T, Ogasawara K, Takaoka A, Tanaka N. 2001. IRF famiy of transcription factors as regulators of host defense. Annu. Rev. Immunol. 19:623-55
248. Kamijo R, Harada H, Matsuyama T, Bosland M, Gerecitano J, et al. 1994. Requirement for transcription factor IRF-1 in NO synthase induction in macrophages. Science 263:1612-15
249. Taki S, Sato T, Ogasawara K, Fukuda T, Sato M, et al. 1997. Multistage regulation of Th1-type immune responses by the transcription factor IRF-1. Immunity 6:673-79
250. Scharton-Kersten T, Contursi C, Masumi A, Sher A, Ozato K. 1997. Interferon consensus sequence binding protein-deficient mice display impaired resistance to intracellular infection due to a primary defect in interleukin 12 p40 induction. J. Exp. Med. 186:1523-34
251. Giese NA, Gabriele L, Doherty TM, Klinman DM, Tadesse-Heath L, et al. 1997. Interferon (IFN) consensus sequence-binding protein, a transcription factor of the IFN regulatory factor family, regulates immune responses in vivo through control of interleukin 12 expression. J. Exp. Med. 186:1535-46
252. Tsukada J, Waterman WR, Koyama Y, Webb AC, Auron PE. 1996. A novel STAT-like factor mediates lipopolysaccharide, interleukin 1 (IL-1), and IL-6 signaling and recognizes a interferon activation site-like element in the IL1β gene. Mol. Cell. Biol. 16:2183-94
253. Kovarik P, Stoiber D, Novy M, Decker T. 1998. Stat1 combines signals derived from IFN- and LPS receptors during macrophage activation. EMBO J. 17:3660-68
254. Ohmori Y, Hamilton TA. 2001. Requirement for STAT1 in LPS-induced gene expression in macrophages. J. Leukoc. Biol. 69:598-604
255. Takeda K, Akira S. 2000. STAT family of transcription factors in cytokine-mediated biological responses. Cytokine Growth Factor Rev. 11:199-207
256. Gao JJ, Filla MB, Fultz MJ, Vogel SN, Russell SW, et al. 1998. Autocrine/paracrine IFN-α/β mediates the lipopolysaccharide-induced activation of transcription factor Stat1 in mouse macrophages: pivotal role of Stat1 in induction of the inducible nitric oxide synthase gene. J. Immunol. 161:4803-10
257. Toshchakov V, Jones BW, Perera PY, Thomas K, Cody MJ, et al. 2002. TLR4, but not TLR2, mediates IFN-β-induced STAT1α/β-dependent gene expression in macrophages. Nat. Immunol. 3:392-98
258. Brightbill HD, Plevy SE, Modlin RL, Smale ST. 2000. A prominent role for Sp1 during lipopolysaccharide-mediated induction of the IL-10 promoter in macrophages. J. Immunol. 164:1940-51
259. Ma W, Lim W, Gee K, Aucoin S, Nandan D, et al. 2001. The p38 mitogen-activated kinase pathway regulates the human interleukin-10 promoter via the activation of Sp1 transcription factor in lipopolysaccharide-stimulated human macrophages. J. Biol. Chem. 276:13664-74
260. Akira S, Takeda K, Kaisho T. 2001. Toll-like receptors: critical proteins linking innate and acquired immunity. Nat. Immunol. 2:675-80
261. Banchereau J, Steinman RM. 1998. Dendritic cells and the control of immunity. Nature 392:245-52
262. Reis e Sousa C. 2001. Dendritic cells as sensors of infection. Immunity 14:495-98
263. Schnare M, Barton GM, Hol AC, Takeda K, Akira S, et al. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2:947-50
264. Kaisho T, Hoshino K, Iwabe T, Takeuchi O, Yasui T, et al. 2002. Endotoxin can induce MyD88-deficient dendritic cells to support Th2 cell differentiation. Int. Immunol. 14:695-700
265. -/- setting. Immunity 16:429-39
266. Pulendran B, Palucka K, Banchereau J. 2001. Sensing pathogens and tuning immune responses. Science 293:253-56
267. Pulendran B, Kumar P, Cutler CW, Mohamadzadeh M, van Dyke T, et al. 2001. Lipopolysaccharides from distinct pathogens induce different classes of immune responses in vivo. J. Immunol. 167:5067-76
268. Barton GM, Medzhitov R. 2002. Control of adaptive immune responses by Toll-like receptors. Curr. Opin. Immunol. 14:380-83
269. Lipford GB, Heeg K, Wagner H. 1998. Bacterial DNA as immune cell activator. Trends Microbiol. 6:496-500
270. Krieg AM. 2000. The role of CpG motifs in innate immunity. Curr. Opin. Immunol. 12:35-43
271. Azuma I, Seya T. 2001. Development of immunoadjuvants for immunotherapy of cancer. Int. Immunopharmacol. 1:1249-59
272. Luft T, Pang KC, Thomas E, Hertzog P, Hart DN, et al. 1998. Type I IFNs enhance the terminal differentiation of dendritic cells. J. Immunol. 161:1947-53
273. Le Bon A, Schiavoni G, D'Agostino G, Crcesser I, Belardelli F, et al. 2001. Type I interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity 14:461-70
274. Blanco P, Palucka AK, Gill M, Pascual V, Banchereau J. 2001. Induction of dendritic cell differentiation by IFN-α in systemic lupus erythematosus. Science 294:1540-43
275. Cella M, Jarrossay D, Facchetti F, Alebardi O, Nakajima H, et al. 1999. Plasmacytoid monocytes migrate to inflamed lymph nodes and produce large amounts of type I interferon. Nat. Med. 5:919-23
276. - dendritic cells. Eur. J. Immunol. 31:3403-12
277. Dalod M, Salazar-Mather TP, Malmgaard L, Lewis C, Asselin-Paturel C, et al. 2002. Interferon α/β and interleukin 12 responses to viral infections: pathways regulating dendritic cell cytokine expression in vivo. J. Exp. Med. 195:517-28
278. Thoma-Uszynski S, Stenger S, Takeuchi O, Ochoa MT, Engele M, et al. 2001. Induction of direct antimicrobial activity through mammalian toll-like receptors. Science 291:1544-47
279. Tzou P, Reichhart JM, Lemaitre B. 2002. Constitutive expression of a single antimicrobial peptide can restore wild-type resistance to infection in immunodeficient Drosophila mutants. Proc. Natl. Acad. Sci. USA 99:2152-57
280. Zasloff M. 2002. Antimicrobial peptides of multicellular organisms. Nature 415:389-95
281. Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, et al. 2000. Secretion of microbicidal a-defensins by intestinal Paneth cells in response to bacteria. Nat. Immunol. 1:113-18
282. Lehrer RI, Ganz T. 2002. Defensins of vertebrate animals. Curr. Opin. Immunol. 14:96-102
283. Birchler T, Seibl R, Buchner K, Loeliger S, Seger R, et al. 2001. Human Toll-like receptor 2 mediates induction of the antimicrobial peptide human β-defensin 2 in response to bacterial lipoprotein. Eur. J. Immunol. 31:3131-37
284. Zychlinsky A, Prevost MC, Sansonetti PJ. 1992. Shigella flexneri induces apoptosis in infected macrophages. Nature 358:167-68
285. Choi K-B, Wong F, Harlan JM, Chaudhary PM, Hood L, et al. 1998. Lipopolysaccharide mediates endothelial apoptosis by a FADD-dependent pathway. J. Biol. Chem. 273:20185-88
286. Bannerman DD, Tupper JC, Erwert RD, Winn RK, Harlan JM. 2002. Divergence of bacterial lipopolysaccharide proapoptotic signaling downstream of IRAK-1. J. Biol. Chem. 277:8048-53
287. Hu WH, Johnson H, Shu HB. 2000. Activation of NF-κB by FADD, Casper, and caspase-8. J. Biol. Chem. 275:10838-44
288. Schaub FJ, Han DK, Liles WC, Adams LD, Coats SA, et al. 2000. Fas/FADD-mediated activation of a specific program of inflammatory gene expression in vascular smooth muscle cells. Nat. Med. 6:790-96
289. Bannerman DD, Tupper JC, Kelly JD, Winn RK, Harlan J. 2002. The Fas-associated death domain protein suppresses activation of NF-κB by LPS and IL-1β. J. Clin. Invest. 109:419-25
290. Bachmann MF, Kopf M. 2001. On the role of the innate immunity in autoimmune disease. J. Exp. Med. 193:F47-50
291. Leadbetter EA, Rifkin IR, Hohlbaum AM, Beaudette BC, Shlomchik MJ, et al. 2002. Chromatin/IgG complexes activate autoreactive B cells by dual engagement of IgM and Toll-like receptors. Nature 416:603-7